Literature DB >> 3543342

Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo.

D Brown, M R Henzl, M E LePage, L L Tsao, A E Izu, K A Walker, G D Adamson, W Droegmuller.   

Abstract

A double-blind, parallel study was conducted comparing a new imidazole derivative, butoconazole nitrate, with placebo and miconazole nitrate for the treatment of vulvovaginal candidiasis. Patients were randomly assigned to six treatment regimens. Butoconazole was found to be an effective antifungal agent in both the six- and three-day treatment schedules. The incidence of local side effects from both tested imidazoles was low.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3543342

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

Review 1.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 2.  Candidiasis (vulvovaginal).

Authors:  Des Spence
Journal:  BMJ Clin Evid       Date:  2010-01-05

Review 3.  Candidiasis (vulvovaginal).

Authors:  Juliana Ester Martin Lopez
Journal:  BMJ Clin Evid       Date:  2015-03-16

4.  Development of a liquid chromatography-tandem mass spectrometry method for determination of butoconazole nitrate in human plasma and its application to a pharmacokinetic study.

Authors:  Meng-Meng Jia; Ying Zhou; Xiao-Meng He; Yi-Lai Wu; Hu-Qun Li; Hui Chen; Wei-Yong Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

5.  Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis.

Authors:  Fen Qin; Quan Wang; Chunlian Zhang; Caiyun Fang; Liping Zhang; Hailin Chen; Mi Zhang; Fei Cheng
Journal:  Infect Drug Resist       Date:  2018-10-17       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.